Summit Therapeutics
SMMT
#1317
Rank
A$20.85 B
Marketcap
$28.27
Share price
-0.86%
Change (1 day)
832.64%
Change (1 year)

Summit Therapeutics (SMMT) - P/B ratio

P/B ratio as of November 2024 : 31.4

According to Summit Therapeutics 's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Summit Therapeutics - P/B ratio (from 2020 to 2020)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-3123.5248.52%
2022-12-316.76114.05%
2021-12-313.16-35.14%
2020-12-314.87102.41%
2019-12-312.40475.27%
2018-12-310.4179-92.9%
2017-12-315.88-90.92%
2016-12-3164.82738.92%
2015-12-312.28
2014-12-31N/A
2013-12-31N/A
2012-12-31N/A
2011-12-31N/A
2010-12-31N/A
2009-12-31N/A
2008-12-31N/A
2007-12-31N/A
2006-12-31N/A
2005-12-31N/A
2004-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
8.67-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA
1.01-96.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.44-104.59%๐Ÿ‡บ๐Ÿ‡ธ USA